US EditionWhite Paper: The Medicaid Drug Rebate Program and Considerations for Generic Markets
Summary by Avalere Health
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
White Paper: The Medicaid Drug Rebate Program and Considerations for Generic Markets
Generic drugs play a key role in the US healthcare system. In Medicaid, coverage of outpatient prescription drugs is governed by the Medicaid Drug Rebate Program (MDRP), which requires manufacturers to pay rebates in return for guaranteed coverage. These rebates include a base rebate and an inflation rebate that applies when a drug’s average manufacturer price (AMP) increases faster than the rate of inflation. Intended to restrain drug price inc…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
